Market

Forays into the Rs 800-crore nasal inhaler segment

The company plans to commence shipping of Ashlyna immediately

Cipla has been awarded US $188.95 million of Global Fund ARV tender

Under the agreement Mylan will distribute Sovaldi and Harvoni in India

31 corporates have shown growth more than 10 per cent amongst the top 50

Above 20,000 potential buyers including 1,400 international buyers from 180 countries are anticipated

NuFFooDS Expo will be organised concurrently

Emphasises on the fact that clinical research needs to be built on a quality and ethical framework

Other topics at the ASSOCHAM Pharma Summit included changes in drug pricing, the impending revision of NLEM-2011, and amendments…

With growing awareness and understanding of fungal infections, India's anti fungal market is slated to grow phenomenally in the…

Preventive healthcare might be the buzzword, but a company down South is working towards a paradigm shift in personalised…

Gabriel Perera, Director, Product Development and Business Development – Asia, Blackmores, talks about tropical diseases in India…

BDMA in association with DoP will conduct following programmes. The '2015 - The Year of Active Pharmaceutical

Half a billion children vaccinated: Gavi

The US Food and Drug Administration (FDA) has banned imports from Indian generic drug maker Ipca Laboratories' plant at Ratlam in…

To roll vaccines for measles, BCG, rabies (Human), Japanese encephalitis and Hib for supplying to National Immunisation programme

The transaction is expected to close in the second half of 2015, subject to regulatory approvals and certain closing conditions

The visit aimed to understand the efforts USP is making in India to create standards for medicines, ensure full safety and quality…

Panacea Biotec, among the largest producer of vaccines and a research based pharmaceutical and biotechnology company has been…

The conference was organised for pharma marketing personnel with an aim to share the importance of ‘Why and How of Digital…